All advanced analyses performed internally

Asbestos

Mesothelioma, lung cancer, and other asbestos-related disease. Analyses can include germline assessment for BAP1 and other susceptibility variants, somatic profiling of tumor tissue, and consideration of competing exposures.

Talc

Ovarian and mesothelioma matters. Analyses include differentiation between cosmetic and industrial talc considerations, somatic profiling, and signature analysis where the underlying literature supports it.

Benzene and aromatic solvents

Leukemia and lymphoma matters, with attention to clonal hematopoiesis and the signature literature.

Glyphosate and other herbicides

Lymphoma matters, with attention to differential etiology and exposure characterization.

PFAS and per- and polyfluoroalkyl matters

Kidney, testicular, and other matters, with attention to evolving science and population-level exposure considerations.

Silica and respirable mineral dust

Silicosis, lung cancer, and autoimmune sequelae.

Hexavalent chromium and heavy metals

Occupational and community exposure matters.

Pharmaceutical product liability

Matters where pharmacogenomic considerations are central, including drug metabolism variants and adverse-event genetics.

Drinking water and groundwater

Source attribution and exposure characterization.

If your matter is not on this list

This list reflects matter types where genomic analysis has been demonstrably useful. The relevant question for any specific matter is whether genomic analysis is informative, not whether the matter type is on a published list. Contact us to discuss.

Discuss your matter

Conflict checks are completed before any matter-specific information is exchanged.